Allstate has released its June 2025 monthly report detailing estimated catastrophe losses and policies in force, which is available on their investor website. This announcement provides stakeholders ...

Analysts have set 12-month price targets for Allstate, revealing an average target of $216.88, a high estimate of $250.00, ...

It is hard to get excited after looking at Allstate's (NYSE:ALL) recent performance, when its stock has declined 6.9% over the past three months. However, the company's fundamentals look pretty ...

Allstate (ALL) concluded the recent trading session at $206.39, signifying a -0.2% move from its prior day's close.

Allstate has continued to outperform the financial services sector over the past several years, including 2024, and analysts remain bullish on the stock’s prospects.

The report also takes into account additional factors that could influence Allstate’s stock performance in the near term, including the potential sale of the Health & Benefits segment and the ...

Allstate Corporation (ALL -3.04%) is one of those stocks that had a rough month, dropping 7.7% in July, according to S&P Global Market Intelligence.

Allstate's Q1 earnings fell short of expectations, but its performance wasn't as poor as that implied by the bottom line miss. See why ALL stock is a buy.

I believe Allstate’s current share price presents investors with an opportunity to buy a wonderful company at a massive discount. Read more on ALL stock here.

Allstate's (NYSE:ALL) stock up by 9.6% over the past three months. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term ...